Switch theme
Sign up to access all valuation multiples
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
1999
2.4K+
LTM Revenue $506M
LTM EBITDA $75.2M
$785M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Proto Labs has a last 12-month revenue (LTM) of $506M and a last 12-month EBITDA of $75.2M.
In the most recent fiscal year, Proto Labs achieved revenue of $501M and an EBITDA of $61.3M.
Proto Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Proto Labs valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $506M | XXX | $501M | XXX | XXX | XXX |
| Gross Profit | $227M | XXX | $223M | XXX | XXX | XXX |
| Gross Margin | 45% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $75.2M | XXX | $61.3M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 12% | XXX | XXX | XXX |
| EBIT | $44.4M | XXX | $25.5M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $38.2M | XXX | $16.6M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Proto Labs's stock price is $37.
Proto Labs has current market cap of $879M, and EV of $785M.
See Proto Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $785M | $879M | XXX | XXX | XXX | XXX | $1.54 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Proto Labs has market cap of $879M and EV of $785M.
Proto Labs's trades at 1.6x EV/Revenue multiple, and 12.8x EV/EBITDA.
Equity research analysts estimate Proto Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Proto Labs has a P/E ratio of 23.0x.
See valuation multiples for Proto Labs and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $879M | XXX | $879M | XXX | XXX | XXX |
| EV (current) | $785M | XXX | $785M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 10.4x | XXX | 12.8x | XXX | XXX | XXX |
| EV/EBIT | 17.7x | XXX | 30.8x | XXX | XXX | XXX |
| EV/Gross Profit | 3.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 23.0x | XXX | 53.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 11.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialProto Labs's last 12 month revenue growth is 3%
Proto Labs's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Proto Labs's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Proto Labs's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Proto Labs and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| BigRep | XXX | XXX | XXX | XXX | XXX | XXX |
| Infinitt Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Renishaw | XXX | XXX | XXX | XXX | XXX | XXX |
| Xaar | XXX | XXX | XXX | XXX | XXX | XXX |
| Solid World Grp | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Proto Labs acquired XXX companies to date.
Last acquisition by Proto Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . Proto Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Proto Labs founded? | Proto Labs was founded in 1999. |
| Where is Proto Labs headquartered? | Proto Labs is headquartered in United States of America. |
| How many employees does Proto Labs have? | As of today, Proto Labs has 2.4K+ employees. |
| Who is the CEO of Proto Labs? | Proto Labs's CEO is Mr. Suresh Krishna. |
| Is Proto Labs publicy listed? | Yes, Proto Labs is a public company listed on NYS. |
| What is the stock symbol of Proto Labs? | Proto Labs trades under PRLB ticker. |
| When did Proto Labs go public? | Proto Labs went public in 2012. |
| Who are competitors of Proto Labs? | Similar companies to Proto Labs include e.g. BigRep, Infinitt Healthcare, Renishaw, Xaar. |
| What is the current market cap of Proto Labs? | Proto Labs's current market cap is $879M |
| What is the current revenue of Proto Labs? | Proto Labs's last 12 months revenue is $506M. |
| What is the current revenue growth of Proto Labs? | Proto Labs revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Proto Labs? | Current revenue multiple of Proto Labs is 1.6x. |
| Is Proto Labs profitable? | Yes, Proto Labs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Proto Labs? | Proto Labs's last 12 months EBITDA is $75.2M. |
| What is Proto Labs's EBITDA margin? | Proto Labs's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Proto Labs? | Current EBITDA multiple of Proto Labs is 10.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
